Editas Medicine (NASDAQ:EDIT) Stock, Earnings Estimates, EPS, And Revenue

Editas Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 26
EPS Estimate
$-0.580
Quarterly Revenue Estimate
$19.97 M
Annual Revenue
(as of Sep 30)
$61.76 M

Analyze the earnings history of Editas Medicine using advanced sorting and filters.

Data brought to you by Benzinga APIs

Editas Medicine (EDIT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-04$-0.75$-0.783.85 %
Jun 20242024-08-07$-0.82$-0.70-17.1 %
Mar 20242024-05-08$-0.76$-0.67-13.4 %
Dec 20232024-02-28$-0.23$-0.5457.4 %

Editas Medicine (EDIT) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-04$61.00K$2.69M-97.7 %
Jun 20242024-08-07$513.00K$5.08M-89.9 %
Mar 20242024-05-08$1.14M$7.90M-85.6 %
Dec 20232024-02-28$60.05M$7.94M656.3 %

FAQ

Q

When is Editas Medicine (NASDAQ:EDIT) reporting earnings?

A

Editas Medicine (EDIT) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Editas Medicine (NASDAQ:EDIT)?

A

The Actual EPS was $-0.75, which beat the estimate of $-0.78.

Q

What were Editas Medicine’s (NASDAQ:EDIT) revenues?

A

The Actual Revenue was $61K, which missed the estimate of $2.7M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch